SUMMARY

In the dog, stepped increases in isoflurane concentration (up to 1.5 MAC) caused peripheral and coronary vasodilatation. In the presence of significant decreases in arterial pressure (-35%). contractility (-46%), cardiac output (-17%) and coronary perfusion pressure (-40%), coronary blood flow remained unchanged, while the effective coronary vascular resistance was halved. The coronary reserve, estimated by the hyperaemic response to short periods (10 s) of coronary occlusion was reduced by the stepped increases in isoflurane concentration. Linear relationships were observed between peak hyperaemic flow, volume repayment, repayment:deficit ratio and coronary perfusion pressure. The vasodilatation induced by isoflurane was of such magnitude that, at 1.5 MAC, the repayment:deficit ratio was close to unity, indicating that the vasodilatory reserve was a/most exhausted.
ventilation instituted with an inspired gas mixture of 60% oxygen in nitrogen. Normocapnia was assured by capnometry and anaesthesia was maintained during the surgical preparation with 1.5-2.0% halothane. A heating element, incorporated into the operating table, maintained body temperature between 37 °C and 38 °C, as measured by an oesophageal thermistor probe. The left carotid artery was exposed, and a rigid 7-French gauge cannula introduced and advanced into the aortic root for pressure measurement and blood sampling. Through a left lateral thoracotomy the pericardium was fashioned into a cradle to support the heart and another rigid 7-French gauge cannula was inserted into the apex of the left ventricle to allow high fidelity measurements of pressure. Differentiation of this signal yielded LV dP/dt. Dissection of the left anterior descending (anterior interventricular) coronary artery just distal to the origin of the first diagonal branch allowed a snare and an electromagnetic flow transducer of appropriate size to be applied. Aortic blood flow was measured using a second cuff-type electromagnetic flow transducer. Miniature ultrasonic displacement transducers were implanted in subendocardial myocardium in the territory supplied by the exposed artery and in territory supplied by the circumflex coronary artery. The technique of sonomicrometry has been reported from this laboratory in the past [12] . In this instance it was used to monitor myocardial welfare, and document the presence or absence of ischaemic dysfunction.
After completion of the surgical preparation, the anaesthetic was changed to isoflurane, a period of 60 min was allowed for stabilization at 1 MAC (determined as 1.13 % isoflurane in end-tidal gas), and the anaesthetic breathing circuit was changed. After calibration of all equipment, the animals were exposed to stepped increases in the inspired concentration of isoflurane so that, after 10 min at each concentration, a stable alveolar value had been achieved, as shown in table I.
When equilibrium conditions were achieved at each dose, an accurately-timed 10-s occlusion was applied to the exposed coronary artery. The measurements illustrated in figure 1 were recorded from the mean coronary blood flow trace: mean flow, occlusion volume deficit, peak hyperaemic flow, duration of hyperaemic response, volume repayment and the repayment: deficit ratio. Following the temporary occlusion of the LAD artery, the return of normal segmental contractile function was assured before proceeding to the next dose. At the end of the experiment, 5-ml aliquots of blood were injected into the LAD to calibrate the flow transducer.
Recordings of the occlusion and hyperaemic responses were made at a paper speed of 50 mm s" 1 , and the areas representing the volume deficit during arterial occlusion and the volume repayment during the hyperaemic response were determined by planimetry. At the end of the investigation the territory supplied by the LAD artery was defined by the injection of Evans blue dye into the vessel at the site of the flow transducer. Careful weighing of the stained muscle allowed the calibration of mean flow recordings in ml min" 1 per 100 g of muscle. Coronary perfusion pressure was calculated by subtracting LV end-diastolic pressure from aortic diastolic pressure, and "effective coronary vas- cular resistance" (ECVR) was calculated by dividing coronary perfusion pressure by mean flow. The data were analysed using two-way analysis of variance and Duncan's multiple range test. Linear regression analysis was performed using the least squares method. P < 0.05 was considered significant; all values are given as mean + SEM. (table II) There was a dose-related reduction in effective coronary vascular resistance, so that at 1.5 MAC isoflurane, mean ECVR had decreased to 53 % of the control value (P < 0.001). These changes indicated a significant mean reduction in coronary perfusion pressure, while coronary flow remained unchanged.
RESULTS
Coronary circulation
Because coronary blood flow was essentially unchanged as the isoflurane concentration was increased, the mean volume deficit was unchanged. However, peak hyperaemic flow ( -51%), volume repayment ( -76%), and the ratio of repayment to deficit ( -78%) decreased markedly. The duration of the hyperaemic response was also significantly reduced ( -49%). As illustrated in figure 2, peak hyperaemic flow and volume repayment were found to bear linear relationships to coronary perfusion pressure. However, the hyperaemic response was not abolished, as indicated by the repayment: deficit ratio of 1.0 at 1.5 MAC isoflurane.
Cardiac function
Some of the indices of global cardiovascular function recorded simultaneously with the values of coronary haemodynamics are shown in table III.
While heart rate increased significantly (+18 %), peak left ventricular pressure (-33 %), mean arterial pressure (-35%), LV dP/dt (-46 %) and peak left ventricular power (-56 %) all decreased significantly. Systemic vascular resistance decreased in a dose-dependent fashion ( -20%). Cardiac output was reduced by 17% at 1.5 MAC isoflurane.
Ischaemic contractile dysfunction developed in the territory supplied by the LAD artery during the brief coronary artery occlusions, but dysfunction never persisted beyond the duration of the hyperaemic response. We take this to mean that any oxygen debt incurred by the occlusion had been fully repaid, and that there was no lasting ischaemia in the region. 
DISCUSSION
Blood flow to all segments of the circulation is dependent on the arterial driving pressure. The relationship between coronary blood flow and arterial pressure is complicated by three additional factors: extravascular compressive forces, diastolic chamber pressures, and the effects of increased pressure on myocardial oxygen consumption. The pressure-flow relationships are also influenced by autoregulation and by the critical closing pressure [13] .
Acute increases in arterial pressure and wall stress augment myocardial metabolism and coronary blood flow. Although autoregulation tends to maintain coronary blood flow when pressure increases, the increases in wall stress and oxygen demand produce coronary vasodilatation because local metabolic influences are dominant. Conversely, within limits, decreases in arterial pressure are associated with decreases in wall stress, oxygen requirements and blood flow.
Autoregulation is attenuated by any intervention which impairs the function of the smooth muscle in coronary vessels. In this study, we have confirmed that isoflurane causes coronary vasodilatation. As the isoflurane concentration was increased, all indices of myocardial oxygen demand, with the exception of a small increase in heart rate, were depressed in parallel with coronary perfusion pressure, and yet LAD coronary artery blood flow remained unchanged. Thus isoflurane caused coronary vasodilatation, as indicated by the significant and large reduction in effective coronary vascular resistance. Similar observations were reported by Tarnow and colleagues [1] from canine studies, with the additional information that coronary sinus oxygen content was increased at 1 MAC isoflurane. Our findings are in agreement with several recent experimental studies in which coronary vasodilatation was demonstrated [2, [4] [5] [6] . Sill and colleagues [6] have shown that the site of vasodilatation is in the intramyocardial and not epicardial vessels. Despite this "luxury" perfusion, the capacity for further vasodilatation in response to oxygen lack was retained, as demonstrated by a mean repayment: deficit ratio that did not become inferior to unity.
While Katz and Linder [14] were the first to describe coronary reactive hyperaemia, its quantitative characteristics in dogs were determined by Coffman and Gregg in 1960 [15] . Peak hyperaemic flow is primarily dependent on minimal coronary vascular resistance (maximal vasodilatation) and the prevailing coronary driving pressure [16] ; therefore, a linear relationship is observed between peak hyperaemic flow and coronary perfusion pressure. This was confirmed in the present study ( fig. 2) . The rate at which the reactive hyperaemia dissipates parallels the rate at which myocardial concentrations of adenosine decrease [17] and, by the end of this response, concentrations of lactate and high energy phosphates have returned to normal [18] . The repayment volume is almost always greater than the deficit volume, so that the repayment: deficit ratio is greater than unity, being of the order of 4 at high coronary perfusion pressures. In this study, the repayment: deficit ratio was 1 at 1.5 MAC isoflurane and the peak hyperaemic flow was about~ 150 % of resting flow. Thus over the range of isoflurane concentrations investigated, further vasodilatation occurred in response to brief periods of occlusion, indicating that local regulation was not abolished. Moreover, the restoration of normal contractile patterns in the territory supplied by the temporarily occluded vessel indicates that reserve coronary vasodilatation was enough to repay the oxygen debt. The attenuation of the hyperaemic response to coronary occlusion with deepening isoflurane anaesthesia reflected the decreases in perfusion pressure. This latter conclusion is supported by the linear relationships that were obtained by regression analyses of both peak hyperaemic flow ( fig. 2 ) and volume repayment with coronary perfusion pressure ( fig. 3) . The regression coefficients were almost identical to those of Dole and co-workers [16] , whose experiments were performed in a more dynamic preparation under steady-state chloralose anaesthesia with measurements of hyperaemic response under conditions of constant perfusion pressure.
In terms of Klocke's [10] concept of coronary vascular reserve (that is, the difference between resting coronary arterial blood flow and flow measured during maximal vasodilatation (in this case post-occlusion hyperaemia)), under the same conditions of oxygen consumption and coronary perfusion pressure, 1.5 MAC isoflurane appeared to have substantially decreased the flow reserve. However, at 1.5 MAC isoflurane resting flow may still have been surplus to requirements. While vasodilatation cannot be doubted, the reduction in vascular resistance may have been the result of a reduction in extravascular as well as vascular resistance [19] . Isoflurane could reduce the extravascular resistance by reducing the intramyocardial tension. The observed dose-related decreases in both systemic arterial pressure and inotropic state indicate that systolic wall tension was reduced, while isovolumic relaxation and end-diastolic pressures and dimensions remained essentially unchanged [11] . If the reduction in extravascular resistance was the major determinant of coronary vasodilatation, the critical closing pressure [13] should be low during isoflurane anaesthesia. The mean critical closing pressure, determined by extrapolation of the linear relationship between peak hyperaemic coronary blood flow and coronary perfusion pressure to the zero flow point (17.7 mm Hg) was similar to the values observed during studies of enflurane [11] , and halothane anaesthesia [20] . Thus the isoflurane-induced coronary vasodilatation in normal coronary arteries is not associated with a greater decrease in coronary closing pressure than that observed with both enflurane and halothane; isoflurane does not appear to cause a greater reduction in extravascular coronary resistance than other halogenated anaesthetics.
During the studies reported by Reiz and colleagues [8, 9] , myocardial ischaemia occurred in patients with coronary artery disease and was attributed to a "steal" phenomenon, caused by isoflurane because of its vasodilator properties. Our canine experiments have confirmed that isoflurane causes coronary vasodilatation. We have found that the capacity for further coronary vasodilatation in response to oxygen lack is reduced, but that autoregulation is not abolished. In these circumstances, the diminution in coronary vascular reserve is directly related to the decreases in coronary perfusion pressure.
